A micellar liquid chromatography method for the quantification of abacavir, lamivudine and raltegravir in plasma
Impacte
Scholar |
Altres documents de l'autoria: Vives-Peris, Vicente; Villarreal Traver, Mónica; Casas Breva, Inmaculada; Carda-Broch, Samuel; Esteve-Romero, Josep
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/7013
comunitat-uji-handle3:10234/8638
comunitat-uji-handle4:
INVESTIGACIONAquest recurs és restringit
http://dx.doi.org/10.1016/j.jpba.2014.06.009 |
Metadades
Títol
A micellar liquid chromatography method for the quantification of abacavir, lamivudine and raltegravir in plasmaAutoria
Data de publicació
2014-09Editor
ElsevierCita bibliogràfica
PERIS-VICENTE, Juan, et al. A micellar liquid chromatography method for the quantification of abacavir, lamivudine and raltegravir in plasma. Journal of pharmaceutical and biomedical analysis, 2014, 98: 351-355.Tipus de document
info:eu-repo/semantics/articleVersió de l'editorial
http://www.sciencedirect.com/science/article/pii/S0731708514002970Versió
info:eu-repo/semantics/publishedVersionParaules clau / Matèries
Resum
An analytical methodology based on micellar liquid chromatography has been developed to quantify abacavir, lamivudine and raltegravir in plasma. These three antiretroviral drugs are prescribed as a set in highly active ... [+]
An analytical methodology based on micellar liquid chromatography has been developed to quantify abacavir, lamivudine and raltegravir in plasma. These three antiretroviral drugs are prescribed as a set in highly active antiretroviral therapy to acquired immunodeficiency syndrome patients. The experimental procedure consists in the dilution of the sample in micellar media, followed by filtration and, without cleanup step. The analytes were resolved in less than 30 min using a mobile phase of 0.05 M sodium dodecyl sulphate at pH 7, running at 1 mL min−1 under isocratic mode at room temperature through a C18 column (125 × 4.6 mm, 5 μm particle size). The UV detection wavelength was set at 260 nm. The method was successfully validated following the requirements of ICH guidelines in terms of: linear range (0.25–2.5 μg mL−1), linearity (r2 > 0.990), intra- and interday precision (<6.8%) and accuracy (92.3–104.2%) and robustness (<7.1%). To the extent of our knowledge, this is the first published method to quantify these three drugs in plasma. Several blood samples from AIDS patients taking this HAART set provided by a local hospital were analyzed with satisfactory results. [-]
Publicat a
Journal of Pharmaceutical and Biomedical Analysis Volume 98, September 2014Drets d'accés
Copyright © 2014 Elsevier B.V. All rights reserved.
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
Apareix a les col.leccions
- QFA_Articles [817]